{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T08:01:31Z","timestamp":1648713691917},"reference-count":0,"publisher":"Portland Press Ltd.","issue":"4","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[1979,4,1]]},"abstract":"<jats:p>1. This study was done to examine the possibility that escape from the sodium retention produced by aldosterone may be associated with an inhibition of prolactin secretion. Plasma prolactin concentrations were determined in seven patients with adrenal adenoma and aldosteronism, before and after unilateral adrenalectomy, at a time when they were in balance on a sodium intake of 109 mmol\/day.<\/jats:p>\n               <jats:p>2. After operation, plasma aldosterone was normal [before operation, 52\u00b77 \u00b1 12\u00b71 (supine), 64\u00b76 \u00b1 9\u00b71 ng\/dl (upright); after operation, 6\u00b78 \u00b1 1\u00b75 (supine), 11\u00b71 \u00b1 3\u00b70 ng\/dl (upright)], while plasma prolactin remained unchanged [before operation, 19\u00b76 \u00b1 2\u00b78 (supine), 15\u00b75 \u00b1 3\u00b73 ng\/ml (upright); after operation, 23\u00b78 \u00b1 2\u00b73 (supine), 11\u00b71 \u00b1 3\u00b70 ng\/ml (upright)].<\/jats:p>\n               <jats:p>3. Our results do not support a role for prolactin in the renal response to aldosterone in man.<\/jats:p>","DOI":"10.1042\/cs0560381","type":"journal-article","created":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T10:35:09Z","timestamp":1438943709000},"page":"381-383","update-policy":"http:\/\/dx.doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prolactin in Primary Aldosteronism"],"prefix":"10.1042","volume":"56","author":[{"given":"R.","family":"D\u00fcsing","sequence":"first","affiliation":[{"name":"Hypertension\u2014Endocrine Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"J. R.","family":"Gill","sequence":"additional","affiliation":[{"name":"Hypertension\u2014Endocrine Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. C.","family":"Bartter","sequence":"additional","affiliation":[{"name":"Hypertension\u2014Endocrine Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/56\/4\/381\/451501\/cs0560381.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/56\/4\/381\/451501\/cs0560381.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T20:01:38Z","timestamp":1638475298000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/56\/4\/381\/72247\/Prolactin-in-Primary-Aldosteronism"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1979,4,1]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1979,4,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs0560381","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[1979,4,1]]}}}